Emerging genomic technologies and the concept of personalized medicine

被引:3
作者
Glinskii, Victoria G. [2 ,3 ]
Glinsky, Gennadi V. [1 ,4 ]
机构
[1] Albany Med Coll, Ctr Med Sci, Div Urol, Dept Surg, Albany, NY 12208 USA
[2] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
[3] Presidents Council Bioeth, Washington, DC USA
[4] Albany Med Coll, Ctr Med Sci, Dept Pathol & Lab Med, Albany, NY 12208 USA
关键词
Genetic Information Nondiscriminatin Act (GINA); genomics; personalized medicine; microarrays; Human Genome Project; genetic testing;
D O I
10.4161/cc.6476
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
With the completion of the Human Genome Project in May 2006, genetic testing for every American is rapidly becoming a reality. As the advanced technology fuels the path towards personalized medicine, genetic nondiscrimination legislation follows closely behind. It seems that the 2007 Genetic Information Nondiscrimination Act (GINA) will finally pass through both chambers of Congress and will be signed by the President, but questions remain. On May 1, 2008, the House passed GINA by a vote of 414 to 1. Why is this the year that genetic nondiscrimination legislation could finally become the reality? Is this the beginning of a new relationship between science and policy, where policy is finally catching up? We examine the answers to these questions through a look at the history of genetic nondiscrimination legislation and where it stands today, including arguments for and against the bill. We conclude by discussing how we can achieve a future of safe personalized medicine for the populous, which would require continuous productive interactions between policymakers and scientists.
引用
收藏
页码:2278 / 2285
页数:8
相关论文
共 17 条
[1]   Genetic nondiscrimination [J].
Billings P.R. .
Nature Genetics, 2005, 37 (6) :559-560
[2]   Stemness genomics law governs clinical behavior of human cancer: Implications for decision making in disease management [J].
Glinsky, Gennadi V. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (17) :2846-2853
[3]   Phenotype-defining functions of multiple non-coding RNA pathways [J].
Glinsky, Gennadi V. .
CELL CYCLE, 2008, 7 (11) :1630-1639
[4]   Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers [J].
Glinsky, Gennadi V. .
STEM CELL REVIEWS, 2007, 3 (01) :79-93
[5]   Death-from-cancer signatures and stem cell contribution to metastatic cancer [J].
Glinsky, GV .
CELL CYCLE, 2005, 4 (09) :1171-1175
[6]  
Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412
[7]   Policy implications of genetic testing: Not just for geneticists anymore [J].
Javitt, GH .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2006, 13 (02) :178-182
[8]   The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease [J].
Lamb, Justin ;
Crawford, Emily D. ;
Peck, David ;
Modell, Joshua W. ;
Blat, Irene C. ;
Wrobel, Matthew J. ;
Lerner, Jim ;
Brunet, Jean-Philippe ;
Subramanian, Aravind ;
Ross, Kenneth N. ;
Reich, Michael ;
Hieronymus, Haley ;
Wei, Guo ;
Armstrong, Scott A. ;
Haggarty, Stephen J. ;
Clemons, Paul A. ;
Wei, Ru ;
Carr, Steven A. ;
Lander, Eric S. ;
Golub, Todd R. .
SCIENCE, 2006, 313 (5795) :1929-1935
[9]   Examining the role of health services research in public policymaking [J].
Lavis, JN ;
Ross, SE ;
Hurley, JE .
MILBANK QUARTERLY, 2002, 80 (01) :125-+
[10]  
*NAT BUS GROUP HLT, 2007, WASH BUS HLTH UPD, V16